NOVALGIN Trademark

Trademark Overview

On Tuesday, May 9, 2023, a trademark application was filed for NOVALGIN with the United States Patent and Trademark Office. The USPTO has given the NOVALGIN trademark a serial number of 79373133. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Tuesday, April 22, 2025. This trademark is owned by A. NATTERMANN & Cie GMBH. The NOVALGIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating pain, fever and inflammation
novalgin

General Information

Serial Number79373133
Word MarkNOVALGIN
Filing DateTuesday, May 9, 2023
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateTuesday, April 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating pain, fever and inflammation
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 5, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameA. NATTERMANN & Cie GMBH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Friday, February 2, 2024ASSIGNED TO EXAMINER
Thursday, June 29, 2023SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Wednesday, July 5, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 11, 2023APPLICATION FILING RECEIPT MAILED
Friday, February 9, 2024NON-FINAL ACTION WRITTEN
Saturday, February 10, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 4, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, March 26, 2024REFUSAL PROCESSED BY IB
Monday, March 4, 2024REFUSAL PROCESSED BY MPU
Monday, August 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 3, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Monday, September 9, 2024LETTER OF SUSPENSION E-MAILED
Monday, September 9, 2024SUSPENSION LETTER WRITTEN
Monday, September 9, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, February 3, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, February 28, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Monday, April 21, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, April 22, 2025REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Related Keywords

novalgin fever inflammation pain treating preparations pharmaceutical